Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy
Clinical trial NCT03703882 · COMPLETED
Trial details
- NCT number
- NCT03703882
- Sponsor
- Catabasis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-02
- Primary completion
- 2020-09-22
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.